User:Mr. Ibrahem/Finerenone

Finerenone, sold under the brand name Kerendia, is a medication used to treat chronic kidney disease in people with type 2 diabetes. It is used in those with moderate to severe disease with protein in the urine. It is taken by mouth.

Common side effects include high potassium, low blood pressure, and low sodium. It should not be used in people with adrenal insufficiency. It may interact with grapefruit. There are concerns that use in pregnancy may harm the baby. It is a non-steroidal mineralocorticoid receptor antagonist (MRA).

Finerenone was approved for medical use in the United States in 2021 and Europe in 2022. In the United Kingdom 4 weeks of medication costs the NHS about £52 as of 2022. This amount in the United States is about 560 USD.